Further, IL-6 triggers the activation of the IL-6/JAK/STAT3 pathway which generally enhances proliferation, survival, invasiveness and metastasis of tumor cells, while strongly suppressing the antitumor immune response (Figure 2) [65]. Here, STAT3 is linked to neoplasm.